Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Dendreon Corporation    DNDN   US24823Q1076

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on DENDREON CORPORATION
05/31 DENDREON CORPORATION: Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
05/09 Analysis - A hard day to be a short-seller, one of many this year
05/09 DENDREON CORPORATION: Dendreon Announces First Quarter 2013 Results
05/08 DENDREON CORPORATION: StockCall Pre-Market Review on DNDN, SRPT, ACAD, CTIC, an..
05/06 DENDREON CORPORATION: PROVENGE® (sipuleucel-T) Data Presented at An Annual Scie..
04/24 DENDREON CORPORATION: Dendreon to Host Conference Call on May 9 to Announce Fir..
03/18 DENDREON CORPORATION: Dendreon Announces Securities Class Action Settlement
03/12 DENDREON CORPORATION: Dendreon Announces Webcast Presentation at ROTH Conferenc..
02/25 DENDREON CORPORATION: Dendreon Announces Fourth Quarter and 2012 Year End Resul..
02/20DENDREON CORPORATION: quaterly earnings release
02/15DJGlaxo Research Chief Looks Ahead to Next Wave of New Medicines
02/13 DENDREON CORPORATION: New PROVENGE® (sipuleucel-T) Data to Be Presented at 2013..
01/30 DENDREON CORPORATION: Dendreon to Host Conference Call on February 25 to Announ..
01/11 Wall Street ends flat as rally slows, earnings eyed
01/07 DENDREON CORPORATION: Dendreon Announces Preliminary Fourth Quarter 2012 Revenu..
2012 DENDREON CORPORATION: Dendreon Sells New Jersey Immunotherapy Manufacturing Fac..
2012 DENDREON CORPORATION: Dendreon Announces Webcast Presentations at Upcoming Conf..
2012 DENDREON CORPORATION: Dendreon Appoints Lindsay Rocco to Lead Corporate Communi..
2012 DENDREON CORPORATION: Dendreon Announces Third Quarter 2012 Results
2012 U.S. companies delay results due to Sandy
2012 U.S. companies delay results due to Sandy
2012DJ5TH UPDATE: Companies Postpone Earnings Reports in Light of Hurricane Sandy
2012DJ4TH UPDATE: Companies Postpone Earnings Reports in Light of Hurricane Sandy
2012DJCompanies Postpone Earnings Reports in Light of Hurricane Sandy
2012DJCorrection to 2nd Update on Companies Postponing Earnings Reports
2012 Companies delay results due to hurricane
2012DJCompanies Postpone Earnings Reports in Light of Hurricane Sandy
2012 DENDREON CORPORATION: Dendreon Reschedules Third Quarter 2012 Results to Novemb..
2012DJSome U.S. Firms Delay Earnings Reports
2012 DENDREON CORPORATION: Dendreon to Host Conference Call on October 30 to Announc..
2012 DENDREON CORPORATION: Dendreon to Present at 3rd Annual Cancer Immunotherapy Co..
2012DJDendreon Prostate Drug Receieves Expanded Coverage by Aetna
2012DJAetna Now Will Include Some Patients Whose Cancer Spread to Lungs or Brain -R..
2012 DENDREON CORPORATION: First Patient In Dendreon EU Open-Label Study Begins Sipu..
2012 DENDREON CORPORATION: Dendreon Announces Webcast Presentations at Upcoming Conf..
2012DJU.S. HOT STOCK FUTURES: Hot stocks to watch
2012DJU.S. HOT STOCK FUTURES: Hot stocks to watch
2012 DENDREON CORPORATION: Dendreon Announces Strategic Restructuring to Accelerate ..
2012 DENDREON CORPORATION: Dendreon Announces Second Quarter 2012 Results
2012 EXCLUSIVE: Human Genome rejected Amgen's $7 billion bid in 2010: sources
2012 DENDREON CORPORATION: Dendreon to Host Conference Call on July 30 to Announce S..
2012DJSavient to Reduce Work Force in Restructuring
2012DJSavient to Reduce Work Force By 35% in Restructuring; Names New CEO
2012 DENDREON CORPORATION: John H. Johnson Assumes Role of Chairman
2012 DENDREON CORPORATION: Dendreon Announces Webcast Presentations at Upcoming Conf..
2012 DENDREON CORPORATION: Dendreon Announces Data Presentation at the 2012 American..
2012 DENDREON CORPORATION: Dendreon Announces Presentation of PROVENGE Data at the 2..
2012 DENDREON CORPORATION: Dendreon Reports Net PROVENGE Product Revenues of $82 Mil..
2012 DENDREON CORPORATION: Jennerex Elects Dr. Mitchell H. Gold to Board of Director..
2012 DENDREON CORPORATION: Dendreon to Host Conference Call on May 7 to Announce Fir..
2012 DENDREON CORPORATION: Genesis Biopharma Names Biotech Industry Veteran Hans E. ..
2012DJUS Stocks Rise On Optimism About Greece's Debt Swap
2012DJJ&J Study May Support Wider Use Of Prostate Cancer Drug Zytiga
2012 DENDREON CORPORATION: Dendreon Announces Webcast Presentation at Upcoming Confe..
2012 DENDREON CORPORATION: Dendreon Announces Executive Appointments
2012 DENDREON CORPORATION: Dendreon Reports Fourth Quarter and 2011 Year End Financi..
2012 DENDREON CORPORATION: Dendreon Announces New Time for Fourth Quarter and Year-E..
2012 DENDREON CORPORATION: Dendreon to Host Conference Call on February 27 to Announ..
2012DJDENDREON CORPORATION: UPDATE : Dendreon Names New CEO To Spur Sales Growth For ..
2012DJDENDREON CORPORATION: Dendreon Picks Savient CEO Johnson To Succeed Gold At Hel..
2012 DENDREON CORPORATION: Dendreon Announces CEO and Chairman Succession Plan
2012 DENDREON CORPORATION: Dendreon Announces Presentation of PROVENGE Data at the A..
2012 DENDREON CORPORATION: Dendreon Announces Fourth Quarter Revenues and Update on ..
2012 DENDREON CORPORATION: Dendreon Announces Webcast Presentation at J.P. Morgan He..
2011 DENDREON CORPORATION: Dendreon Agrees to Sell VICTRELIS? (boceprevir) Royalty I..
2011 DENDREON CORPORATION: Dendreon Announces Webcast Presentation at Upcoming Confe..
2011 DENDREON CORPORATION: Dendreon Announces the Centers for Medicare and Medicaid ..
2011 DENDREON CORPORATION: Dendreon Announces Election of Dennis M. Fenton to Board ..
2011 DENDREON CORPORATION: Dendreon Reports Third Quarter 2011 Financial Results
2011 DENDREON CORPORATION: Dendreon Announces Webcast Presentations at Upcoming Conf..
2011 DENDREON CORPORATION: Dendreon Begins Enrollment in Phase 2 Neu-ACT Trial for S..
2011 DENDREON CORPORATION: Dendreon to Host Conference Call on November 2, 2011 to A..
2011 DENDREON CORPORATION: Five Days Remain before Deadline in Class-action Lawsuit ..
2011 DENDREON CORPORATION: Law Office of Brodsky & Smith, LLC Announces Class Action..
2011 DENDREON CORP: Dendreon Announces Company Restructuring and Provides Update on ..
1  2  3Next
Advertisement
Chart
Duration : Period :
Dendreon Corporation Technical Analysis Chart | DNDN | US24823Q1076 | 4-Traders
Income Statement Evolution
Dendreon Corporation : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Copyright © 2013 Surperformance. All rights reserved.